Hospital
Leflore County Hospital Authority
Leflore County Hospital Authority was paid $5.04M by Medicaid between Jan 2018 and Dec 2024, across 68 billing codes. Its largest line is 99283, emergency room visit (moderate) — 45% of everything it billed.
33Billing provider infoLEFLORE COUNTY HOSPITAL AUTHORITY
POTEAU, OK 74953
POTEAU, OK 74953
33aNPI1396767158assigned 07/24/2006
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$5.04M
24GClaims62,427
24DCodes billed68
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,193 | $437K | |
| 2019 | 7,496 | $597K | |
| 2020 | 6,257 | $544K | |
| 2021 | 8,865 | $749K | |
| 2022 | 13,836 | $1.15M | |
| 2023 | 13,820 | $1.01M | |
| 2024incomplete | 6,960 | $563K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 45% | 14,068 | 13,948 | $2.28M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 37% | 8,272 | 8,124 | $1.88M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.5% | 2,561 | 2,541 | $128K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.5% | 1,019 | 1,002 | $124K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.1% | 1,041 | 1,034 | $104K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 9,726 | 9,055 | $63K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.1% | 295 | 290 | $56K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 866 | 851 | $53K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.0% | 613 | 611 | $51K |
| 87428 | <1% | 1,514 | 1,499 | $44K | |
| 80053 | Comprehensive metabolic panel | <1% | 3,581 | 3,511 | $31K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 312 | 306 | $29K |
56 more codes
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,893 | $27K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,785 | $22K |
| 85027 | <1% | 2,890 | $16K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 121 | $10K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,481 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 676 | $10K |
| 87400 | <1% | 458 | $10K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 268 | $9K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 230 | $8K |
| 81001 | <1% | 1,911 | $7K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 216 | $6K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 963 | $6K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 112 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 344 | $5K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 145 | $5K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 118 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 281 | $4K |
| 81025 | <1% | 452 | $4K | |
| 83735 | <1% | 647 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 17 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 26 | $2K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 51 | $2K |
| 87634 | <1% | 29 | $2K | |
| 80305 | <1% | 163 | $2K | |
| 81000 | <1% | 514 | $2K | |
| 84439 | <1% | 226 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 231 | $2K |
| 85018 | <1% | 600 | $1K | |
| 80061 | Lipid panel | <1% | 106 | $1K |
| 87420 | <1% | 98 | $1K | |
| 80076 | <1% | 120 | $836.83 | |
| 87807 | <1% | 71 | $827.15 | |
| 83655 | <1% | 68 | $735.46 | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 13 | $659.04 |
| 83690 | <1% | 107 | $607.65 | |
| 87088 | <1% | 90 | $601.12 | |
| 85014 | <1% | 268 | $600.74 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 37 | $520.11 |
| 70210 | <1% | 30 | $468.93 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 285 | $468.66 |
| 87480 | <1% | 27 | $459.79 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 13 | $378.72 |
| 83880 | <1% | 12 | $327.65 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 37 | $320.24 |
| 84484 | <1% | 29 | $292.27 | |
| 82950 | <1% | 67 | $288.58 | |
| 87430 | <1% | 17 | $221.28 | |
| 87070 | <1% | 15 | $115.04 | |
| 36600 | <1% | 13 | $84.60 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 83 | $81.00 |
| 85730 | <1% | 13 | $64.20 | |
| 85610 | <1% | 13 | $45.84 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 25 | $3.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 14 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 24 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRIFFIS, TIFFANY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Leflore County Hospital Authority | Poteau, OK | $3.68M |
| Leflore County Hospital Authority | Poteau, OK | $1.46M |
| Leflore County Hospital Authority | Heavener, OK | $510K |
| Leflore County Hospital Authority | Poteau, OK | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.